Bausch Health (BHC) Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
Bausch + Lomb Corporation Common Shares (BLCO)
Company Research
Source: Globe and Mail, The
Chief Financial Officer — Jean-Jacques Charhon Chief Medical Officer and Head of Research and Development — Jonathan Sadeh Need a quote from a Motley Fool analyst? Email pr@fool.com TAKEAWAYS Revenue (Total Company) -- $2.524 billion, up 12% reported and 7% organic, driven by Salix and Solta performance. Adjusted Gross Margin -- 70.9%, an increase of 100 basis points year over year. Adjusted Operating Expenses -- $1.23 billion, up $29 million from last year, excluding a $1.4 billion goodwill impairment charge related to the Red Sea clinical trial. Adjusted EBITDA (Total Company) -- $837 million, up $176 million or 27% year over year. Adjusted Operating Cash Flow (Total Company) -- $374 million, progressing as expected toward guidance. Revenue (Excluding Bausch + Lomb) -- $1.28 billion, up 14% reported and 9% organic. Adjusted EBITDA (Excluding Bausch + Lomb) -- $673 million, increasing 17% from last year, reflecting margin expansion in Salix and Solta. Adjusted
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation Common Shares news events
Weekly update
A roundup of the hottest topics
BLCO
News
- Bausch + Lomb Corporation (BLCO) Q1 2026 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Bausch + Lomb Swings to Q1 Adjusted Profit, Revenue up [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive OutlookBusiness Wire
- Bausch + Lomb (BLCO) Q1 Earnings Report Preview: What To Look For [Yahoo! Finance]Yahoo! Finance
BLCO
Earnings
- 4/29/26 - Miss
BLCO
Sec Filings
- 4/27/26 - Form 4
- 4/27/26 - Form 4
- 3/10/26 - Form 4
- BLCO's page on the SEC website